Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS) (PREFIMS)

August 5, 2021 updated by: Daphne Kos, KU Leuven

Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS): a Feasibility Study

The current study will add to the current knowledge by combining several electrophysiological techniques to examine the relationship between physiological responses and cognitive fatigue and daily activity performance in a stress- and fatigue-inducing protocol.

The aims of this study are: 1) to evaluate the feasibility and usability of assessing physiological responses in an experimental set-up and 2) to investigate the association between physiological outcomes, experimentally induced stress and cognitive fatigue in people with multiple sclerosis (MS) and healthy controls.

Study Overview

Detailed Description

In an experimental set-up participants (20 people with MS and 20 healthy controls) will perform a high-challenging cognitive protocol to provoke stress and (cognitive) fatigue.

Physiological responses (heart rate variability, skin conductance, body temperature) and brain activity (EEG) will be measured while resting (resting baseline), while speaking as normal (speaking baseline), during protocol performance and following the protocol (post-protocol).

Demographic and clinical characteristics, as well as levels of perceived fatigue, stress, pain, daily activity performance, quality of life and anxiety and depression will be assessed using medical records and questionnaires.

Feasibility and usability will be assessed in participants and researcher(s) by standardized questionnaires.

Study Type

Observational

Enrollment (Anticipated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

A convenience sample of 20 people with currently stable multiple sclerosis (MS) between 18 and 55 years old and able to walk for 100m will be recruited from the National MS Center Melsbroek, as well as 20 age-matched healthy volunteers.

Description

Inclusion Criteria:

  • diagnosis MS, Relapsing Remitting (RR) type (MS group)
  • Expanded Disability Status Scale (EDSS) <6 (MS group)
  • Dutch speaking
  • normal or corrected vision
  • feasible use of computer

Exclusion Criteria:

  • relapse < 3 months (MS group)
  • pregnancy
  • relevant comorbidity (thyroid disease, diabetes, other neurological disorders, metabolic diseases, neuro-endocrine tumor(s)
  • severe cognitive disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Multiple Sclerosis (MS)
People with MS diagnosis, aged 18-55 years, Relapsing Remitting type, EDSS < 6.0, normal vision (if necessary corrected), Dutch speaking.

Baseline measurement is done in two parts: 1) resting for five minutes (no talking, no movement) and 2) speaking at normal pace (2 minutes).

This is immediately followed by a measurement of the physiological response variables during the testing, in which the following protocol is performed in the order presented: 1) SDMT-NBack task-SDMT*-NBacktask**, 2) NBack task-SDMT-NBack task-SDMT. Participants will run either sequence to check for effects of the previous testing. During the conduct of the study, it will be ensured that half of the participants in each group followed Sequence 1 and the other half of the group followed Sequence 2.

During all these measurements, the participant will sit at a table with a computer on which the tests are performed.

*SDMT: Symbol Digit Modalities Test: see description in outcome measures

**N-Back Task: see description in outcome measures

Healthy Controls (HC)
Healthy controls without relevant health conditions (diabetes, thyroid diseases, neurological disorders), non-pregnant, aged 18-55 years, normal vision (if necessary corrected), Dutch speaking.

Baseline measurement is done in two parts: 1) resting for five minutes (no talking, no movement) and 2) speaking at normal pace (2 minutes).

This is immediately followed by a measurement of the physiological response variables during the testing, in which the following protocol is performed in the order presented: 1) SDMT-NBack task-SDMT*-NBacktask**, 2) NBack task-SDMT-NBack task-SDMT. Participants will run either sequence to check for effects of the previous testing. During the conduct of the study, it will be ensured that half of the participants in each group followed Sequence 1 and the other half of the group followed Sequence 2.

During all these measurements, the participant will sit at a table with a computer on which the tests are performed.

*SDMT: Symbol Digit Modalities Test: see description in outcome measures

**N-Back Task: see description in outcome measures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in heart rate variability (time-domain)
Time Frame: immediately post protocol (approx. 2 hours after baseline)
ECG monitoring will be done using the MindMedia NEXUS-10MKII.- Heart Rate Variability will be studied in a time- and frequency domain. For the time-domain following measures are studied: 1) the average normal-normal interval; 2) the standard deviation of normal-normal (SDNN); 3) the Root Mean Square of Successive Differences (RMSSD); 4) the percentage of adjacent normal-normal intervals with differences of more than 50miliseconds. (PNN50).
immediately post protocol (approx. 2 hours after baseline)
Change in heart rate variability (frequency-domain)
Time Frame: immediately post protocol (approx. 2 hours after baseline)
ECG monitoring will be done using the MindMedia NEXUS-10MKII.- Heart Rate Variability will be studied in a time- and frequency domain. For the frequency domain, the changes in the high frequency (HF) and low frequency (LF) will be studied and analysed.
immediately post protocol (approx. 2 hours after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Visual Analogue Scale (VAS) Momentary fatigue
Time Frame: immediately post protocol (approx. 2 hours after baseline)
Momentary fatigue experienced following the protocol using Visual Analogue Scale (VAS) (minimum 0- maximum 10), higher scores indicate higher fatigue.
immediately post protocol (approx. 2 hours after baseline)
Change in Visual Analogue Scale (VAS) Momentary pain
Time Frame: immediately post protocol (approx. 2 hours after baseline)
Momentary pain experienced following the protocol using Visual Analogue Scale (minimum 0- maximum 10), higher scores indicate higher pain.
immediately post protocol (approx. 2 hours after baseline)
Usefulness, Satisfaction, and ease of use Questionnaire (USE)
Time Frame: post protocol (approx. 2 hours after baseline)

The USE is a self-report questionnaire in which 30 items in four dimensions (usefulness, ease of use, ease of learning and satisfaction) are answered on a 7-point Likert scale (1 = disagree, 7 = fully agree) and one not -answer option.

Higher scores indicate higher satisfaction and usefulness.

post protocol (approx. 2 hours after baseline)
NASA Task Load Index (NASA-TLX)
Time Frame: post protocol (approx. 2 hours after baseline)

The NASA-TLX is a self-report questionnaire that measures perceived work-related stress using six dimensions with a focus on mental stress: mental, physical and time-related stress, frustration and execution. The dimensions are assessed on the basis of a semantic differential scale (0-10). The six individual scores are converted to a global score by means of a "paired comparison task" in which "comparison cards" are used prior to the assessment.

Higher scores indicate higher task load.

post protocol (approx. 2 hours after baseline)
Galvanic Skin Response (GSR)
Time Frame: baseline
  • For the monitoring of the GSR, the Mind Media NEXUS-10MKII will be used.
  • Two electrodes will be placed on the palmar side of the left manus. The first electrode is positioned on the phalanx medialis of the index, the second electrode is positioned on the phalanx medialis of the digitus annulare.
  • As the participants will not be exposed to abrupt changes in stimulus presentation, and no expected or unexpected changes in the environment will be present, the tonic Skin Conductance Level (SCL) will be analysed.
baseline
Galvanic Skin Response (GSR)
Time Frame: during protocol (approx. 1 hour after baseline)
  • For the monitoring of the GSR, the Mind Media NEXUS-10MKII will be used.
  • Two electrodes will be placed on the palmar side of the left manus. The first electrode is positioned on the phalanx medialis of the index, the second electrode is positioned on the phalanx medialis of the digitus annulare.
  • As the participants will not be exposed to abrupt changes in stimulus presentation, and no expected or unexpected changes in the environment will be present, the tonic Skin Conductance Level (SCL) will be analysed, using mean microsiemens.
during protocol (approx. 1 hour after baseline)
Galvanic Skin Response (GSR)
Time Frame: immediately post protocol (approx. 2 hours after baseline)
  • For the monitoring of the GSR, the Mind Media NEXUS-10MKII will be used.
  • Two electrodes will be placed on the palmar side of the left manus. The first electrode is positioned on the phalanx medialis of the index, the second electrode is positioned on the phalanx medialis of the digitus annulare.
  • As the participants will not be exposed to abrupt changes in stimulus presentation, and no expected or unexpected changes in the environment will be present, the tonic Skin Conductance Level (SCL) will be analysed, using mean microsiemens.
immediately post protocol (approx. 2 hours after baseline)
Brain activity
Time Frame: baseline

• Electroencephalography (EEG):

  • EEG monitoring will be done using the MindMedia NEXUS-10MKII.
  • Ten20 conductive paste for EEG is used in combination with Ag/AgCl disc electrodes.
  • A positive electrode will be placed on Cz according to the international 10-20 system, a negative electrode will be placed on the left earlobe, and the ground electrode for EEG and ECG measurement will be placed on the right earlobe.

EEG measures:

- The impact of the cognitive fatigue and stress inducing protocol on alpha, beta, delta, and there frequency bands will be studied.

baseline
Brain activity
Time Frame: during protocol (approx. 1 hour after baseline)

• Electroencephalography (EEG):

  • EEG monitoring will be done using the MindMedia NEXUS-10MKII.
  • Ten20 conductive paste for EEG is used in combination with Ag/AgCl disc electrodes.
  • A positive electrode will be placed on Cz according to the international 10-20 system, a negative electrode will be placed on the left earlobe, and the ground electrode for EEG and ECG measurement will be placed on the right earlobe.

EEG measures:

- The impact of the cognitive fatigue and stress inducing protocol on alpha, beta, delta, and there frequency bands will be studied.

during protocol (approx. 1 hour after baseline)
Brain activity
Time Frame: immediately post protocol (approx. 2 hours after baseline)

• Electroencephalography (EEG):

  • EEG monitoring will be done using the MindMedia NEXUS-10MKII.
  • Ten20 conductive paste for EEG is used in combination with Ag/AgCl disc electrodes.
  • A positive electrode will be placed on Cz according to the international 10-20 system, a negative electrode will be placed on the left earlobe, and the ground electrode for EEG and ECG measurement will be placed on the right earlobe.

EEG measures:

- The impact of the cognitive fatigue and stress inducing protocol on alpha, beta, delta, and there frequency bands will be studied.

immediately post protocol (approx. 2 hours after baseline)
Respiration
Time Frame: baseline

Respiration set up:

  • The mind media NEXUS-10 MKII will be used for respiration measurement.
  • An elastic band with sensor will be worn around the trunk at height of the umbilicus.

Respiration measures:

  • Data will solely cover mechanical aspects of breathing.
  • Only the respiration rate will be taken into analyses to study relations with previous neurophysiological measures.
  • Also the breathing rate (BRPM) per minute will be analysed.
baseline
Respiration
Time Frame: during protocol (approx. 1 hour after baseline)

Respiration set up:

  • The mind media NEXUS-10 MKII will be used for respiration measurement.
  • An elastic band with sensor will be worn around the trunk at height of the umbilicus.

Respiration measures:

  • Data will solely cover mechanical aspects of breathing.
  • Only the respiration rate will be taken into analyses to study relations with previous neurophysiological measures.
  • Also the breathing rate (BRPM) per minute will be analysed.
during protocol (approx. 1 hour after baseline)
Respiration
Time Frame: immediately post protocol (approx. 2 hours after baseline)

Respiration set up:

  • The mind media NEXUS-10 MKII will be used for respiration measurement.
  • An elastic band with sensor will be worn around the trunk at height of the umbilicus.

Respiration measures:

  • Data will solely cover mechanical aspects of breathing.
  • Only the respiration rate will be taken into analyses to study relations with previous neurophysiological measures.
  • Also the breathing rate (BRPM) per minute will be analysed.
immediately post protocol (approx. 2 hours after baseline)
Decline in Symbol Digit Modalities Test
Time Frame: immediately post protocol (approx. 2 hours after baseline)

The Symbol Digit Modalities Test (SDMT) Performance

  • The SDMT is frequently used in the normal treatment and follow up of people with MS. Therefore, a customized version for this study is developed.
  • Participants are shown one file with at the top a row as example consisting of symbols with related numbers. Beneath this row, a couple of rows with symbols are shown. The participant has to link the number to the specific symbol according to the example row. This as fast as possible within 90 seconds.

Scores

  • A total score consisting of the total amount of correct answers will be determined.
  • The SDMT will be divided in three equal parts of 30 seconds.
  • For part1 part2, and part3 a correct score will be determined.
  • Additionally, a cognitive fatigability score is determined: the difference between part3 versus part1.
immediately post protocol (approx. 2 hours after baseline)
Decline in N-Back Task
Time Frame: immediately post protocol (approx. 2 hours after baseline)

The N-Back Task (NBT)

Performance:

  • The participants are shown a presentation of a series of letters. The participants have to respond with 'yes' whenever the same letter appeared as two letters previously.
  • The participants perform two versions of this: with a 2- and 1-second interstimulus interval.

Scores:

  • A total score consisting of the total amount of correct answers is determined.
  • The NBT is then divided in three equal parts. For part1, part2, and part3, a total correct score is determined.
  • Additionally, a cognitive fatigability score (i.e. difference between part3 and part1) is determined.
immediately post protocol (approx. 2 hours after baseline)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Fatigue Impact Scale (MFIS)
Time Frame: baseline
The MFIS is a self-report questionnaire used to measure the perceived impact of fatigue on physical, cognitive and psychosocial functioning. The participant answers 21 items on the basis of a 5-point Likert scale (0 = never; 5 = almost always). A higher score on the subscales (physical dimension: 0-36; cognitive dimension: 0-40; psychosocial functioning: 0-8) or in the total score represents a higher degree of fatigue.
baseline
Perceived Stress Scale (PSS)
Time Frame: baseline
Questionnaire on perceived stress in daily life (14 items) The Perceived Stress Scale (PSS) is a self-report questionnaire to measure the perceived stress. In 14 items perceived stress is judged by taking into account the previous month's experiences.. Scoring is done using a 5-point Likert scale (0 = never; 4 = very often), with a maximum score (56) representing a higher degree of perceived stress.
baseline
Hospital Anxiety and Depression Scale (HADS)
Time Frame: baseline
Self-report questionnaire of depression and anxiety (14 items) The HADS is aimed at assessing anxiety and depression in a non-psychiatric setting, without questioning physical complaints such as fatigue.The HADS is a self-report questionnaire of 14 items that are answered on the basis of an ordinal scale with four answer options (0-3). Depression and anxiety subscale scores range from 0-21, with higher scores indicating increased depression or anxiety, respectively.
baseline
Life Balance Inventory (LBI)
Time Frame: baseline

LBI is a self-report assessment instrument containing 53 activities and on a dichotomous scale of yes/no, people have to answer, whether or not they do the activity or want to do the activity. For each item scored 'yes', participants have to rate their satisfaction with the amount of time they have spent doing that activity in the past month compared to the amount of time they wanted to do the activity. The possible answers are: "always less than I want (1), sometimes less than I want (2), about right for me (3), sometimes more than I want (2), always more than I want (1)".

The LBI contains four subscales: (1) Health subscale (ex. Relaxing, getting regular exercise, …), (2) Relationship subscale (ex. Doing things with friends, partner, …), (3) Identity subscale (ex. Taking care of your appearance, participating in religious events, …), (4) Challenge/interest subscale (ex. Working for pay, making music, …).

Higher scores reflect better life balance.

baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Daphne Kos, PhD, KU Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 15, 2020

Primary Completion (ANTICIPATED)

August 30, 2021

Study Completion (ANTICIPATED)

September 1, 2021

Study Registration Dates

First Submitted

January 25, 2021

First Submitted That Met QC Criteria

August 5, 2021

First Posted (ACTUAL)

August 12, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 12, 2021

Last Update Submitted That Met QC Criteria

August 5, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis

Clinical Trials on High-challenging cognitive protocol to provoke stress and (cognitive) fatigue

3
Subscribe